The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Mário Jorge Dinis Ribeiro

    Autor

  • Diogo Miguel Pereira Libânio Monteiro

    Autor

Participantes de fora da FMUP

  • Shah, Shailja
  • El-Serag, Hashem
  • Banks, Matthew
  • Uedo, Noriya
  • Tajiri, Hisao
  • Coelho, Luiz Gonzaga
  • Lahner, Edith
  • Rollan, Antonio
  • Fang, Jing-Yuan
  • Moreira, Leticia
  • Bornschein, Jan
  • Malfertheiner, Peter
  • Kuipers, Ernst J.
  • El-Omar, Emad M.

Unidades de investigação

Abstract

Objective During the last decade, the management of gastric intestinal metaplasia (GIM) has been addressed by several distinct international evidence-based guidelines. In this review, we aimed to synthesise these guidelines and provide clinicians with a global perspective of the current recommendations for managing patients with GIM, as well as highlight evidence gaps that need to be addressed with future research.Design We conducted a systematic review of the literature for guidelines and consensus statements published between January 2010 and February 2023 that address the diagnosis and management of GIM.Results From 426 manuscripts identified, 15 guidelines were assessed. There was consistency across guidelines regarding the purpose of endoscopic surveillance of GIM, which is to identify prevalent neoplastic lesions and stage gastric preneoplastic conditions. The guidelines also agreed that only patients with high-risk GIM phenotypes (eg, corpus-extended GIM, OLGIM stages III/IV, incomplete GIM subtype), persistent refractory Helicobacter pylori infection or first-degree family history of gastric cancer should undergo regular-interval endoscopic surveillance. In contrast, low-risk phenotypes, which comprise most patients with GIM, do not require surveillance. Not all guidelines are aligned on histological staging systems. If surveillance is indicated, most guidelines recommend a 3-year interval, but there is some variability. All guidelines recommend H. pylori eradication as the only non-endoscopic intervention for gastric cancer prevention, while some offer additional recommendations regarding lifestyle modifications. While most guidelines allude to the importance of high-quality endoscopy for endoscopic surveillance, few detail important metrics apart from stating that a systematic gastric biopsy protocol should be followed. Notably, most guidelines comment on the role of endoscopy for gastric cancer screening and detection of gastric precancerous conditions, but with high heterogeneity, limited guidance regarding implementation, and lack of robust evidence.Conclusion Despite heterogeneous populations and practices, international guidelines are generally aligned on the importance of GIM as a precancerous condition and the need for a risk-stratified approach to endoscopic surveillance, as well as H. pylori eradication when present. There is room for harmonisation of guidelines regarding (1) which populations merit index endoscopic screening for gastric cancer and GIM detection/staging; (2) objective metrics for high-quality endoscopy; (3) consensus on the need for histological staging and (4) non-endoscopic interventions for gastric cancer prevention apart from H. pylori eradication alone. Robust studies, ideally in the form of randomised trials, are needed to bridge the ample evidence gaps that exist.

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Dados da publicação

ISSN/ISSNe:
1468-3288, 0017-5749

Gut  BMJ Publishing Group

Tipo:
Article
Páginas:
1607-1617
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 4

Citações Recebidas na Scopus: 3

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • surveillance; gastric carcinoma

Proyectos asociados

Individualized gastric adenocarcinoma early diagnosis and improved patients survival: from liquid biopsies to a comprehensive management approach. (IMAGE)

Investigador Principal: Mário Jorge Dinis Ribeiro

Estudo Clínico Académico (IMAGE) . AgênciaD&C . 2021

Effectiveness of endoscopic resection of colonic lesions > 20mm

Investigador Principal: Mário Jorge Dinis Ribeiro

Estudo Clínico Académico (Colonic lesions) . 2020

Prevalence and Prognostic Importance of Occult Tumor Cells in Gastric Cancer

Investigador Principal: Mário Jorge Dinis Ribeiro

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação